What's breaking now, across thousands of outlets.
The California biotech plans to bring its first drug, enabled by licensing technology from a Chinese drugmaker, into clinical testing for obesity by the end of 2027.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Maharashtra FDA officials found a range of violations, from pest infestations and expired food to unclean equipment and incomplete records on staff health, training and food testing.
A preclinical study in post-menopausal bone loss mouse models found that CADD522, a small-molecule drug targeting RUNX2, protected against osteoporosis, prevented fat gain, and reversed some of the…
Dr. Aneel Paulus, a cancer prevention expert, told Newsweek that people can make "substantial progress" with existing tools.
Survivors and first responders still struggle with physical ailments and poor mental health, 25 years after the Sept. 11, 2001, terror attacks.
